A variante B.1.526 foi prevalente na 2ª onda da pandemia em Nova York, período em que apresentou uma taxa de transmissão até 25% maior que as outras versões do Sars-CoV-2
Especialistas do Departamento de Saúde de Nova York e da Escola de Saúde Pública de Mailman da Universidade de Colúmbia (EUA) descobriram que a cepa Iota da COVID-19.
Especialistas do Departamento de Saúde de Nova York e da Escola de Saúde Pública de Mailman da Universidade de Colúmbia (EUA) descobriram que a cepa Iota da COVID-19.
Is NYC COVID-19 Variant More Severe, Dangerous Than Other Strains? CDC Answers
KEY POINTS
The B.1.526 variant does not carry a higher risk of reinfection
Pfizer and Moderna s COVID-19 vaccines work against the New York variant
The COVID-19 variant first detected in New York City does not appear to cause more severe infections or re-infections at a higher rate, the Centers for Disease Control and Prevention revealed in a new report Wednesday.
A new preliminary analysis by New York City health officials showed that the variant, referred to as B.1.526, does not carry an increased risk for a severe infection or infection after vaccination. However, the study’s lead author urged New Yorkers to continue observing safety protocols even as the local government lifts most of its restrictions.